Endocrinology, Vol 134, 2416-2423, Copyright © 1994 by Endocrine Society

ARTICLES

Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells

JM Quinn, JO McGee and NA Athanasou
University of Oxford, Nuffield, Department of Pathology and Bacteriology, John Radcliffe Hospital, United Kingdom.

Osteoclasts are multinucleated cells which form by fusion of circulating mononuclear hemopoietic precursors. The nature of these precursor cells and the roles bone stromal cells and hormonal factors play in their differentiation to osteoclasts are unknown. We cocultured adherent murine blood monocytes (nonspecific esterase and F4/80 positive; tartrate-resistant acid phosphatase negative) with osteoblastic and fibroblastic stromal cell lines in the presence of 2 x 10(-8) M 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. Tartrate-resistant acid phosphatase and calcitonin (CT) receptor-positive osteoclastic cells, which formed numerous resorption pits in vitro, were noted after only 4 days in coculture with UMR106 osteoblast-like cells. Resorption was seen in cocultures to which as few as 100 peripheral blood mononuclear cells had been added. 1,25-(OH)2D3 and contact with live bone stromal cells were absolute requirements for monocyte differentiation into bone-resorbing cells. Both salmon CT (5 IU/ml) and prostaglandin E2 (10(-6) M) significantly inhibited bone resorption. Thus, a significant proportion of the peripheral blood mononuclear cells in the monocyte fraction are capable of differentiating into cells showing the cytochemical and functional characteristics of osteoclasts. The presence of specific hormonal [1,25-(OH)2D3] and bone stromal cell elements is necessary for this process to occur; the resultant resorption can be modulated by known inhibitors of bone resorption, CT and prostaglandin E2.

This article has been cited by other articles:

				T. Hirayama, L. Danks, A. Sabokbar, and N. A. Athanasou Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis Rheumatology, November 1, 2002; 41(11): 1232 - 1239. [Abstract] [Full Text] [PDF]

				I Itonaga, A Sabokbar, D W Murray, and N A Athanasou Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages Ann Rheum Dis, January 1, 2000; 59(1): 26 - 31. [Abstract] [Full Text]

				Y. Takamatsu, P. J. Simmons, R. J. Moore, H. A. Morris, L. B. To, and J.-P. Levesque Osteoclast-Mediated Bone Resorption Is Stimulated During Short-Term Administration of Granulocyte Colony-Stimulating Factor But Is Not Responsible for Hematopoietic Progenitor Cell Mobilization Blood, November 1, 1998; 92(9): 3465 - 3473. [Abstract] [Full Text] [PDF]

				A. Sabokbar, Y. Fujikawa, D. W Murray, and N. A Athanasou Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption Ann Rheum Dis, October 1, 1998; 57(10): 614 - 618. [Abstract] [Full Text]

				D. M. Biskobing, D. Fan, X. Fan, and J. Rubin Induction of Carbonic Anhydrase II Expression in Osteoclast Progenitors Requires Physical Contact with Stromal Cells Endocrinology, November 1, 1997; 138(11): 4852 - 4857. [Abstract] [Full Text] [PDF]

				A. Sabokbar, Y. Fujikawa, S. Neale, D. W Murray, and N. A Athanasou Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells Ann Rheum Dis, July 1, 1997; 56(7): 414 - 420. [Abstract] [Full Text]

				S. Roux, F. Pichaud, J. Quinn, A. Lalande, C. Morieux, A. Jullienne, and M.-C. de Vernejoul Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors Endocrinology, April 1, 1997; 138(4): 1476 - 1482. [Abstract] [Full Text] [PDF]

				N. A. ATHANASOU Current Concepts Review - Cellular Biology of Bone-Resorbing Cells J. Bone Joint Surg. Am., July 1, 1996; 78(7): 1096 - 1112. [Full Text]